Free Trial
→ This is the “End of Tesla” as we know it… (From Brownstone Research) (Ad)tc pixel

Flag Ship Acquisition Target of Unusually High Options Trading (NASDAQ:ETHZ)

Written by MarketBeat
September 23, 2025

Key Points

  • Flag Ship Acquisition Corp. (NASDAQ:ETHZ) saw a significant spike in options trading, with 59,473 call options bought, marking a 173% increase over its average daily volume.
  • The stock price of Flag Ship Acquisition rose 7.1% during trading to $2.57, with a trading volume surpassing its average by over a million shares.
  • Analyst ratings have turned negative, with Wall Street Zen downgrading Flag Ship Acquisition to a "strong sell" on August 30.
  • MarketBeat previews top five stocks to own in October.

Flag Ship Acquisition Corp. (NASDAQ:ETHZ - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Stock traders bought 59,473 call options on the stock. This represents an increase of approximately 173% compared to the average daily volume of 21,794 call options.

Flag Ship Acquisition Stock Up 7.1%

NASDAQ:ETHZ traded up $0.17 during trading hours on Tuesday, hitting $2.57. The stock had a trading volume of 6,021,088 shares, compared to its average volume of 5,035,573. The company has a market capitalization of $422.59 million, a price-to-earnings ratio of -0.17 and a beta of 0.37. Flag Ship Acquisition has a 1-year low of $0.66 and a 1-year high of $17.75.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Flag Ship Acquisition to a "strong sell" rating in a research note on Saturday, August 30th.

Read Our Latest Analysis on Flag Ship Acquisition

Flag Ship Acquisition Company Profile

(Get Free Report)

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Flag Ship Acquisition Right Now?

Before you consider Flag Ship Acquisition, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Flag Ship Acquisition wasn't on the list.

While Flag Ship Acquisition currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.